skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

10 Total results for product and free and sample content found

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

'Like Water': Pharma Avoids Much Scrutiny In Messy Presidential Debate

Trump and Biden trade barbs in debate that included a suggestion by the president that coronavirus vaccine development delays are political and saw Biden questioned on whether he was contributing to vaccine hesitancy.

Topic US Election 2020 Drug Pricing Policy & Regulation

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip's Five Must-Know Things

Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.

Topic clinical-trials drug-pricing research

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Six Pharma CEOs To Testify In House as Democrats, Trump Compete For Attention On Drug Pricing

US Election Drug Pricing Debate

While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.

Topic us-election-2020 drug-pricing

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

'March In' Plan Unveiled By Democratic Think Tank: A Battle Biopharma Would Welcome?

In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.

Topic us-election-2020 drug-pricing

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Biden's Drug Pricing Administrative Actions Could Focus On Medicare Demos

Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.

Topic us-election-2020 drug-pricing

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Biopharma Needs A Deal On Drug Pricing As Shield Against Possible Democrat Wins - BIO's Greenwood

Outgoing Biotechnology Innovation Organization CEO suggests consideration of price inflation caps instead of 'big discounts' in Medicare Part D and says that industry should fund a cap on beneficiary out-of-pocket costs in the program.

Topic us-election-2020 drug-pricing Legislation

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Biopharma, the White House And Getting Drug Pricing 'Off The Table'

Industry balks at President Trump’s latest effort to force biopharma to negotiate a drug pricing solution, but investors may be pushing for concessions that could head off more onerous policies supported by a Biden White House.

Topic us-election-2020 drug-pricing Regulation

Scrip: 世界の医療用医薬品&製薬産業に関するニュース, Pink Sheet: 世界...

Drug Pricing Update: Strategies and Trends

For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Scrip. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours. 

Topic Drug Pricing

Pink Sheet: 世界の薬事規制と承認審査に関するニュース, Scrip: 世界の医...

Top 5 Drug Pricing Insights and Policies

For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Pink Sheet. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours.

Topic Drug Pricing

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。